EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025

13 Jan 2026 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica and Burberry announce licensing partnership renewal

18 Dec 2025 02:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint

12 Dec 2025 02:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear

10 Dec 2025 12:15:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025

09 Dec 2025 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica creates Scientific Advisory Committee to accelerate the next era of innovation

01 Dec 2025 13:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2025

12 Nov 2025 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution

06 Nov 2025 12:30:00 By Nasdaq GlobeNewswire

Roger Federer Foundation Partners with OneSight EssilorLuxottica Foundation to Bring Vision Care to Thousands of Zambian Schoolchildren

27 Oct 2025 06:28:51 By Nasdaq GlobeNewswire

EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group

16 Oct 2025 12:01:10 By Nasdaq GlobeNewswire

EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions

15 Oct 2025 12:45:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025

09 Oct 2025 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation

06 Oct 2025 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica completes acquisition of Optegra

01 Oct 2025 14:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States

25 Sep 2025 17:30:00 By Nasdaq GlobeNewswire

EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future

17 Sep 2025 21:30:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025

11 Sep 2025 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2025

01 Sep 2025 12:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing

04 Aug 2025 02:00:00 By Nasdaq GlobeNewswire

EssilorLuxottica: Publication of the 2025 Interim Financial Report

29 Jul 2025 12:30:00 By Nasdaq GlobeNewswire